Loading...
In vitro activity of the siderophore cephalosporin, cefiderocol, against molecularly characterized, carbapenem-non-susceptible Gram-negative bacteria from Europe
OBJECTIVES: Many carbapenem-resistant (CR) Gram-negative (GN) pathogens exhibit MDR, meaning few therapeutic options are available for CR-GN infections. Cefiderocol, a siderophore cephalosporin, has demonstrated in vitro efficacy against CR-GN bacteria. In the SIDERO-CR-2014–2016 surveillance study,...
Saved in:
| Published in: | JAC Antimicrob Resist |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Oxford University Press
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8210120/ https://ncbi.nlm.nih.gov/pubmed/34223017 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jacamr/dlaa060 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|